NIH Funds Vaccine Research for Needle-free and Self-Administered Protection Against Pandemic Influenza

U.S. Newswire, February, 2008

To: MEDICAL EDITORS

Contact: Rae Reynolds, V.P. of Business Development of Rocky Mountain Biosystems, Inc., +1-303-667-9265, rreynolds@biofusionary.com

DENVER, Feb. 13 /PRNewswire/ -- Rocky Mountain Biosystems, Inc.(R) (RMBI), a Denver area biomedical technology company, announced receipt of a grant award of approximately $600,000 over two years from the National Institute of Allergy and Infectious Diseases at the National Institutes of Health (NIH) to develop its Self-Administered Vaccination Electromechanical (SAVE) technology for influenza vaccination. In the event of a pandemic, this needle- free system could be rapidly disseminated to provide protection against a deadly influenza outbreak, such as H5N1 influenza or...